PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-s (Q33418542)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-s |
scientific article |
Statements
1 reference
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-s (English)
1 reference
Ralph G Zinner
1 reference
Coleman K Obasaju
1 reference
David R Spigel
1 reference
Robert W Weaver
1 reference
J Thaddeus Beck
1 reference
David M Waterhouse
1 reference
Manuel R Modiano
1 reference
Borys Hrinczenko
1 reference
Petros G Nikolinakos
1 reference
Jingyi Liu
1 reference
Andrew G Koustenis
1 reference
Katherine B Winfree
1 reference
Symantha A Melemed
1 reference
Susan C Guba
1 reference
Waldo I Ortuzar
1 reference
Durisala Desaiah
1 reference
Joseph A Treat
1 reference
Ramaswamy Govindan
1 reference
Helen J Ross
1 reference
1 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference